The apolipoprotein E-deficient mice have a high cholesterol level and high chances for the development of atherosclerosis, whereas perhexiline decreases systemic cholesterol levels via activation of the KLF14 pathway [31]. This evidence concerns the gene KLF14 and atherosclerosis.